R1317
Appearance
The topic of this article may not meet Wikipedia's general notability guideline. (December 2024) |
Clinical data | |
---|---|
Other names | 1-Cinnamyl-4-phenyl-4-piperidinol propionate |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C23H27NO2 |
Molar mass | 349.474 g·mol−1 |
3D model (JSmol) | |
| |
|
R1317 is a desmethylprodine analog in which the N-methyl group is replaced by a cinnamyl group. This change in sidechain endows the compound with an increase in potency. The compound is 261 times more potent[clarification needed] than meperidine in mice[1] and 1100 times more potent in rats. In another article it was stated to be 785 times more potent than meperidine.[2]
Despite this high potency, it is not the most potent 4-phenylpiperidine-reverse ester ever created. The most potent 4-phenylpiperidine-reverse ester ever created is R1480.[1] R1480 is stated to have a potency 1500-3180 times higher than meperidine in mice and 3040 times higher in rats.
References
[edit]- ^ a b J., Paul A.; Eddy, Nathan B. (1960). "Compounds Related to Pethidine--IV. New Genaral Chemical Methods of Increading the Analgesic Activity of Pethidine". Journal of Medicinal and Pharmaceutical Chemistry. 2: 31–45. doi:10.1021/jm50008a003. PMID 14406754.
- ^ Elpern, Bill; Wetterau, William; Carabateas, Philip; Grumbach, Leonard (1958). "Strong Analgesics. The Preparation of Some 4-Acyloxy-1-aralkyl-4-phenylpiperidines". Journal of the American Chemical Society. 80 (18): 4916–4918. Bibcode:1958JAChS..80.4916E. doi:10.1021/ja01551a038.